Covance Q2 soaring thanks to Sanofi acquisitions
Covance’s Q2 results marked a hefty uptick in early stage operating income thanks to the sites it took from Sanofi.
Archives for July 27, 2011
INC Research CEO reflects on Kendle acquisition
INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.
BASF posts Q2 gains, but share price falls on lacklustre guidance
BASF posts Q2 results and says economic uncertainties mean industrial customers are still cautious about placing orders.
Market share gains drive MWV medical pump growth
MeadWestvaco (MWV) has reported increased market share is driving double-digit growth in sales of medical pumps.
E-therapeutics restart drug discovery unit
Network pharmacology specialist E-Therapeutics has restarted its drug discovery unit in response to improving economic climate and investor demand.
Pii adds trial scale HME capacity
Pharmaceutics International (Pii) has expanded its range of formulation and process development services with the addition of bioavailability boosting hot-melt extrusion (HME) capabilities.
FDA says Cetero faked docs, manipulated samples at lab
Sponsors face having to redo lab work after the FDA alleged Cetero falsified records and manipulated samples to meet acceptance criteria.
Dr Reddy’s partnership to bolster Fujifilm API biz
Fujifilm is to strengthen its API and formulations business by forming a Japan-focused joint venture with Dr Reddy’s.